Hypotensive lipid-containing biodegradable intraocular implants and related methods
AssigneeAllergan, Inc.
InventorPatrick M. Hughes
Life of this patent
Estimating the term…
Abstract
Biocompatible intraocular implants include a prostamide component and a biodegradable polymer that is effective in facilitating release of the prostamide component into an eye for an extended period of time. The prostamide component may be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. The implants may be placed in an eye to treat or reduce at least one symptom of an ocular condition, such as glaucoma.
Claims6
A method of reducing intraocular pressure, the method comprising placing a biodegradable intraocular implant into the anterior chamber of an eye of a patient in need thereof, the implant comprising latanoprost and a biodegradable polymer matrix that releases an amount of the latanoprost from the implant effective to reduce the intraocular pressure in the eye of the patient in need thereof, wherein the amount of the latanoprost is released into the eye for a period of time greater than about one week to less than about six months after the implant is placed into the anterior chamber of the eye.
Dependencies are inferred from the claim text.